Clinical Trials in Baltimore

Showing 10721-10740 of 23,476 trials

Therapy for High-Risk HPV 16-Positive Oropharynx Cancer Patients

NCT04001413

Combination immune checkpoint inhibitor and DNA vaccine will result in clearance of HPV DNA biomarkers (oral and/or plasma) for patients with persistent HPV-16 E6/E7 DNA (HPV biomarker) after treatment with curative intent.

HPV Positive Oropharyngeal Squamous Cell CarcinomaOropharynx CancerHPV-Related Carcinoma

Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsStarted Sep 2019

Baltimore, Maryland, United States • New York, New York, United States • New York, New York, United States +1 more locations

COMPLETEDPhase 2< 1 mile

Safety and Efficacy Study of RA101495 in Subjects With Generalized Myasthenia Gravis

NCT03315130

The purpose of the study is to evaluate the safety and efficacy of RA101495 in patients with generalized Myasthenia Gravis (gMG). Subjects will be randomized in a 1:1:1 ratio to receive daily SC doses of 0.1 mg/kg RA101495, 0.3 mg/kg RA101495, or matching placebo for 12 weeks.

Generalized Myasthenia Gravis

Ra Pharmaceuticals45 participantsStarted Oct 2017

Mobile, Alabama, United States • Carlsbad, California, United States • Los Angeles, California, United States +27 more locations

Therapy for High-Risk HPV 16-Positive Oropharynx Cancer Patients

Safety and Efficacy Study of RA101495 in Subjects With Generalized Myasthenia Gravis

Find Trials by Condition in Baltimore

Efficacy and Safety of AXA1665 in Cirrhotic Subjects With Prior Overt Hepatic Encephalopathy

Respiratory Syncytial Virus (RSV) Investigational Vaccine in Infants Aged 6 and 7 Months Likely to be Unexposed to RSV

A Study of FOR46 in Patients With Relapsed or Refractory Multiple Myeloma (RRMM)

Temozolomide and Radiation Therapy With or Without Cediranib Maleate in Treating Patients With Newly Diagnosed Glioblastoma

A Study of Immune Responses to the Virus That Causes COVID-19

Study to Evaluate the Efficacy and Safety of Larazotide Acetate for the Relief of CeD Symptoms

A Clinical Assessment Study in X-Linked Myotubular Myopathy (XLMTM) Subjects

Marizomib for Recurrent Low-Grade and Anaplastic Supratentorial, Infratentorial, and Spinal Cord Ependymoma

The Scleroderma Biorepository and Pathogenesis Study (STOP Scleroderma)

Phase 3 Study of Intranasal Carbetocin (LV-101) in Patients With Prader-Willi Syndrome

A Study To Assess The Tolerability And Clinical Activity Of Gedatolisib In Combination With Palbociclib/Letrozole Or Palbociclib/Fulvestrant In Women With Metastatic Breast Cancer

Propranolol for Protracted Labor

A Study of the Communication of Genetic Test Results By Telephone: A Multi-Center Study

ET-01 in Subjects With Lateral Canthal Lines, LCL-209

Trial of 4-Hydroxytamoxifen (4-OHT) Gel in Women Aimed at Reducing Dense Breast Tissue

Remote Wheelchair Skills Training Efficacy

Phase 2 Safety and Efficacy Study of Zilucoplan (RA101495) to Treat PNH Patients Who Have an Inadequate Response to Eculizumab

Prone Positioning Short-term Effects on Tissue Oxygen Saturation in Critical COVID-19 Patients